LUPIN
Lupin is a global pharmaceutical company originating in India with a broad portfolio spanning generics, biosimilars, specialty medicines, and biotech CDMO services. It maintains a worldwide manufacturing and research footprint, focusing on key therapeutic areas such as respiratory, cardiovascular, tuberculosis, and diabetes management. The company emphasizes innovation and integrated healthcare delivery across multiple markets, including India, the US, the UK, and other regions. Lupin highlights its commitment to research and development, manufacturing excellence, and social responsibility through its broader community initiatives.
No recent news for this company.